Hennion & Walsh Asset Management, Inc. Editas Medicine, Inc. Transaction History
Hennion & Walsh Asset Management, Inc.
- $2.35 Billion
- Q2 2025
A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 246,092 shares of EDIT stock, worth $1.02 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
246,092
Previous 257,460
4.42%
Holding current value
$1.02 Million
Previous $321,000
68.54%
% of portfolio
0.02%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding EDIT
# of Institutions
216Shares Held
45.4MCall Options Held
476KPut Options Held
338K-
Black Rock Inc. New York, NY7.78MShares$32.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.16MShares$29.6 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.96MShares$8.13 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.88MShares$7.77 Million0.0% of portfolio
-
State Street Corp Boston, MA1.85MShares$7.65 Million0.0% of portfolio
About Editas Medicine, Inc.
- Ticker EDIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,737,200
- Market Cap $285M
- Description
- Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...